CSIR launches ayurvedic anti-diabetic drug BGR-34

Kozhikode, Feb 3 (IANS) The Council for Scientific and Industrial Research (CSIR) on Wednesday launched BGR-34 — the country’s first anti-diabetic ayurvedic drug designed for Type-2 diabetes mellitus which has been scientifically validated for its efficacy and safety.

BGR-34 has been developed jointly by the National Botanical Research Institute (NBRI) and the Central Institute for Medicinal and Aromatic Plants (CIMAP) which are the research units of CSIR and located in Lucknow.

BGR-34 costs Rs.5 per tablet and is available at all major chemist counters in Kerala.

Speaking at the launch, A. K. S. Rawat, senior principal scientist, CSIR-NBRI, said six crore of the adult Indian population has been diagnosed with diabetes.

“We are sure that eminent medical professionals will now recommend it to their patients suffering from Type-2 diabetes mellitus for quicker and consistent response. CSIR’s premier research institutions have developed and established the efficacy of BGR-34,” said Rawat.

Scientists of NBRI and CIMAP made an in-depth study of over 500 renowned ancient herbs and finally identified the six best herbs listed in ayurvedic ancient texts to be combined in different fractions and quantities and processed meticulously to develop this new drug.

V. Rao, principal scientist CSIR-NBRI, said BGR-34 is a unique product that manages the lives of human beings suffering from diabetes.

“This product passed several battery of tests and showed hypoglycaemic activity in experimental subjects,” said Rao.

For the purpose of quality commercial production and extended distribution, Aimil Pharmaceuticals (I) Ltd, known for its innovative, quality herbal and ayurvedic products, has been transferred the rights and technical knowhow to produce and market it for medical use.

K. K. Sharma, managing director of Aimil Pharmaceuticals, said they were happy to partner institutes of such repute for passing on its benefits to the people.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here